Cite
Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2.
MLA
Strand, Vibeke, et al. “Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2.” Rheumatology & Therapy, vol. 8, no. 4, Dec. 2021, pp. 1827–44. EBSCOhost, https://doi.org/10.1007/s40744-021-00377-x.
APA
Strand, V., Van den Bosch, F., Ranza, R., Leung, Y.-Y., Drescher, E., Zueger, P., Saffore, C. D., Lertratanakul, A., Lippe, R., & Nash, P. (2021). Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2. Rheumatology & Therapy, 8(4), 1827–1844. https://doi.org/10.1007/s40744-021-00377-x
Chicago
Strand, Vibeke, Filip Van den Bosch, Roberto Ranza, Ying-Ying Leung, Edit Drescher, Patrick Zueger, Christopher D. Saffore, Apinya Lertratanakul, Ralph Lippe, and Peter Nash. 2021. “Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2.” Rheumatology & Therapy 8 (4): 1827–44. doi:10.1007/s40744-021-00377-x.